Good MorningEquities rebounded on Wednesday despite another round of bearish news that included the PPI data and earnings from JPMorgan Chase. The PPI data shows producer prices accelerating more than expected to the fastest pace on record. This data is sure to lead to another increase in the CPI data next month or later in the year which brings us to the JPMorgan Chase report. The company says it is bracing for increased economic risks and we think it is a wise decision.
The impacts of Russia's invasion of Ukraine are only beginning to show up in the data and results and those impacts are not good. Rising fuel costs and disruptions to trade are only the tip of the iceberg and threaten to throw the global economy into a recession. The next hurdle for the market will come today with an earnings report from at least half a dozen of the world's largest financial institutions. If they report more of what JPMorgan Chase reported the market sell-off could resume with increased vigor. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Basic Materials | |
Instead of guessing if inflation has peaked, buy these stocks instead
The market got a double whammy in a shortened trading week. On April 12, the consumer price index (CPI) showed came in at 8.5%. The fact that the “core” CPI number went down gave some investors reason to believe th... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Medical | |
A Dividend Aristocrat is a company that is part of the S&P 500 index that not only consistently pays dividends, but regularly increases the size of its payouts. The S&P 500 index tracks the performance of the 500 largest companies listed on stock exchanges in the U.S.
You can think of the... Read the Full Story |
|
Medical | |
Profitability Outlook Accelerated In Wake Of OrganiGram Results
OrganiGram (NASDAQ: OGI) reached a turning point in Q1 in which profitability became truly in reach. The company updated its outlook for profitability from Q4 to Q3 of the current fiscal year and the outlook is accelerating again. T... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Consumer Staples | |
The Analysts Are Driving These Dividend Stocks Higher
Dividend growth stocks are among our favorite investment groups because you get so much bang for your buck. Not only do the companies pay dividends but business growth typically means capital appreciation as well. What this boils down to is c... Read the Full Story |
|
Utilities | | Utility services holding company Exelon Corporation (NYSE: EXC) stock has been on a tear hitting decade long highs. The Company owns energy generation facilities utilizing nuclear, hydroelectric, biomass, solar, and wind to accommodate its 10.5 million customers. Rising oil prices have lifted other ... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Retail/Wholesale | |
Shares of discount retailer Ross Stores (NASDAQ: ROST) were among the best performing US equities this week as shares popped as much as 7% from where they closed last Friday. The catalyst for the pop was a price target increase from the team at Credit Suisse, who upped it from $118 to $125. Even a... Read the Full Story |
|
Markets | |
When putting together a stock investing strategy, why not consider investing in dividend stocks? Dividend stocks typically offer a beneficial one-two punch: regular dividend payments and consistent appreciation of stock prices over time.
But what are "dividend stocks?" Investing in dividend stock... Read the Full Story |
|
Transportation | | Railroad freight car and equipment manufacturer Greenbrier Companies (NYSE: GBX) stock took a sharp nose dive in March 2022 ahead of strong fiscal Q2 2022 earnings report. The Company is successfully navigating supply chain disruptions and inflationary pressures on commodities resulting in high raw ... Read the Full Story |
|
Technology | |
The Institutions Drive Volatility For Palo Alto Networks
Insiders have been selling Palo Alto Networks (NASDAQ: PANW) on a regular basis but it is nothing for shareholders to be worried about. The sales are small, periodic, incredibly regular, and spread among a wide range of execs and board mem... Read the Full Story |
|
Retail/Wholesale | |
Carmax Buckles Under Strain Of Economic Headwinds
Carmax (NYSE: KMX) put in a good quarter to be sure but the report is rife with evidence inflation is hurting the economy. The company produced a solid increase in revenue versus the year-ago period but the gains are driven almost entirely by pri... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California. | | View Today's Stock Pick |
|
